 SILVER SPRING, Md., Feb. 15, 2021 GLOBE NEWSWIRE -- Aziyo Biologics, Inc. Nasdaq: AZYO, a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today announced that it plans to release its fourth quarter and full year earnings results after market close on Monday, March 1, 2021. Management will host a conference call to review the Companys financial performance starting at 4:30 p.m. Eastern Time 1:30 p.m. Pacific Time on the same day. The conference call will be concurrently webcast. 